期刊文献+

三氧化二砷提高多发性骨髓瘤ARH-77细胞对NK细胞杀伤敏感性的研究 被引量:4

Effects of arsenic trioxide on NK cell cytotoxicity against multiple myeloma cell lines ARH-77
下载PDF
导出
摘要 目的研究三氧化二砷(arsenic trioxide,ATO)前后人多发性骨髓瘤ARH-77对NK细胞杀伤细胞敏感性的变化,并初步探讨其机制。方法分别应用CCK-8法和台盼蓝染色法测算ATO对ARH-77细胞株的50%抑制量(IC50)和细胞活性;乳酸脱氢酶释放法检测ATO作用前后ARH-77细胞对NK细胞的杀伤敏感性。流式细胞仪检测ARH-77细胞表面NKG2D配体(MICA/B、ULBP1、ULBP2、ULBP3)和HLA-Ⅰ类分子表达以及ATO作用前后的细胞周期变化。结果ATO对ARH-77细胞的IC50为5.0μmol/L。NK细胞杀伤ATO作用前后ARH-77细胞的活性有显著差异(P<0.05)。ATO作用后,ARH-77细胞发生G1/S期阻滞,同时其表面MICA/B、ULBP1、ULBP3表达显著升高,二者之间差异有统计学意义(P<0.05)。ULBP2和HLA-Ⅰ类分子无明显变化(P>0.05)。结论ATO能提高ARH-77细胞NKG2D配体(MICA/B、ULBP1、ULBP3)表达;从而使其对NK细胞的杀伤敏感性增强。 Objective To explore the effects of arsenic trioxide(ATO)on NK cell cytotoxicity against multiple myeloma cell lines ARH-77.Methods The IC50 and survival rates of ARH-77 cells treated by 2.5,5.0,10 μmol/L ATO for 24,48,96 h were measured by cck-8 assay and trypanblau staining method,respectively.Cytotoxicities against ARH-77 cell of NK cells isolated from 3 healthy volunteers were analyzed by LDH releasing assay at different effector-to-target cell ratios(E:T)before and after treated by ATO.The expressions ...
出处 《免疫学杂志》 CAS CSCD 北大核心 2009年第2期154-157,共4页 Immunological Journal
关键词 三氧化二砷 多发性骨髓瘤 NK细胞 NKG2D配体 arsenic trioxide multiple myeloma NK cell NKG2D ligand
  • 相关文献

参考文献1

二级参考文献1

共引文献5

同被引文献38

  • 1谭竞,刘霆,朱焕玲,孟文彤,余江.三氧化二砷对多发性骨髓瘤骨髓基质细胞增殖及分泌细胞因子的影响[J].中国实验血液学杂志,2006,14(2):258-261. 被引量:6
  • 2梅家转,周健,郭坤元,魏红梅.低表达MICA/MICB导致NK细胞对人鼻咽癌多药耐药细胞(CNE2/DDP)杀伤活性下降[J].中国肿瘤生物治疗杂志,2006,13(5):349-352. 被引量:8
  • 3梅家转,牛新清,郭坤元,周健,魏红梅.K562和K562/AO2细胞HLA I类分子与MICA/B的表达及其对NK细胞杀伤活性的影响[J].中国实验血液学杂志,2007,15(2):288-291. 被引量:10
  • 4Barlogie B, Desikan R, Edddlemon P, et al. Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: Identification of prognostic factors in a phase 2 study of 169 patients [J]. Blood, 2001, 98(2): 492-494.
  • 5Lee SR, Kim SJ, Park Y, et al. Bortezomib and melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma [ J]. Korean J Hematol, 2010, 45 (3) : 183- 187.
  • 6Efebera YA, Qureshi SR, Cole SM, et al. Reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed multiple myeloma [ J ]. Biol Blood Marrow Transplant, 2010, 16 (8) : 1122-1129.
  • 7Fionda C, Soriani A, Malgarini G, et al. Heat shock protein-90 inhibitors increase MHC class I-related chain A and B ligand expression on multiple myeloma cells and their ability to trigger NK cell degranulation [J]. J Immunol, 2009, 183(7) : 4385-4394.
  • 8Ryosei N, Jeanette B, Andreas B, et al. In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity [ J]. Blood, 2008, 112 ( 8 ) : 2563-2574.
  • 9Benitez AC, Dai Z, Mann HH, et al. Expression, signaling proficiency, and stimulatory function of the NKG2D lymphocyte receptor in human cancer cells [Jl. Proc Natl Acad Sci U S A, 2011, 108(10) : 4081-4086.
  • 10Vivier E, Tomasello E, Paul P1. Lymphocyte activation via NKG2D: Towards a new paradigm in immune recognition [J].Curr Opin Immunol, 2002, 14 ( 3 ) : 3062-3111.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部